Unlocking the anticancer activity of gambogic acid: a shift towards ferroptosis via a GSH/Trx dual antioxidant system
- 2 April 2024
- journal article
- research article
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 218, 26-40
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applicationsCell, 2022
- Tumor-specific carrier-free nanodrugs with GSH depletion and enhanced ROS generation for endogenous synergistic anti-tumor by a chemotherapy-photodynamic therapyChemical Engineering Journal, 2021
- Gambogic acid: A shining natural compound to nanomedicine for cancer therapeuticsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2020
- Breakdown of an Ironclad Defense System: The Critical Role of NRF2 in Mediating FerroptosisCell Chemical Biology, 2020
- Iron homeostasis and oxidative stress: An intimate relationshipBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2019
- The development of the concept of ferroptosisFree Radical Biology and Medicine, 2019
- Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and ProgressionCancer Cell, 2015
- Gambogic acid induces apoptosis in hepatocellular carcinoma SMMC-7721 cells by targeting cytosolic thioredoxin reductaseFree Radical Biology and Medicine, 2014
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Tert-butylhydroquinone induces mitochondrial oxidative stress causing Nrf2 activationCell Biology and Toxicology, 2010